The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.
“The FDA is concerned about the advance prescribing of mifepristone for this use,” an anonymous FDA spokesperson reportedly told the German-owned Politico Friday. “Mifepristone is not approved for advance provision of a medical abortion.”
A new campaign by a national organization of pro-life OB/GYNs is challenging the narratives of the abortion industry and its allies in the medical establishment, particularly its top assertion that abortion is health care.
“We know that 93% of practicing OB/GYNs do not perform abortion – and these are women’s healthcare specialists,” Dr. Christina Francis, CEO-elect of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) told The Star News Network.
The abortion industry and its allies in politics, the media, and establishment medicine have made the false claim that women’s health is endangered by state pro-life laws because abortions cannot be performed in these states when the life of the mother is at risk.
Legal and medical experts, however, are explaining how that claim is false and constitutes “misinformation,” since pro-life laws in all states clearly articulate the lives of pregnant women are protected under them.